Latest News & Features
Europe
The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function claims, increasing the risk for infringers even if they modify products. Marisa Woutersen unpacks the debate over the UPC’s flexible approach to added matter and the urgency criteria. 25 February 2025
Biotechnology
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing technology found invalid | Natera also faces separate trade secrets claims from Guardant Health over cancer blood tests. 25 February 2025
Americas
Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler. 25 February 2025
Americas
British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent infringement | Earlier ruling ‘nullifies a statutory mechanism for expediting access to generic drugs and breaks sharply with precedent on inducement’ says UK pharma company. 20 February 2025
Americas
Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments. 20 February 2025
Americas
Patent Trial and Appeal Board rules all challenged claims were unpatentable | Decision follows Federal Circuit review that revived Apple’s challenge. 18 February 2025
Careers
David Por joins the firm’s Paris team as partner | New hire brings two decades of experience, including in healthcare and life sciences. 18 February 2025
Americas
The former USPTO director has filed her first amicus brief since rejoining private practice, arguing that instructions issued in a Texas court are “legally incorrect”. She tells Sarah Speight why this matters. 18 February 2025
Unified Patent Court
Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v Suinno Mobile & AI Technologies Licensing. 13 February 2025
Americas
Nominations open as D&I values face growing backlash on both sides of the pond | Research shows equality efforts result in creativity and productivity | Categories include Influential Women in IP, Diversity Champions, and Future Champions. 13 February 2025